XOLREMDI
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for XOLREMDI, covering 2024-04-26 to 2026-08-20. Get the full timeline:
Most recent: EMA Authorised: Xolremdi (mavorixafor) — Norgine B.V.
3 regulatory and trial events tracked for XOLREMDI, covering 2024-04-26 to 2026-08-20. Get the full timeline:
Most recent: EMA Authorised: Xolremdi (mavorixafor) — Norgine B.V.